The results showed that the percentage of IL‐17A+CD4+ cells was increased, and the percentage of Foxp3+ CD25+ CD4+ cells was reduced in patients with ITP (Figure 1a and b). This evidence concerns the gene CD4 and autoimmune thrombocytopenic purpura.